![Inflammatory Bowel Disease – An intestinal manifestation]()
by MyBiosource Editorial Team | Dec 23, 2018 | News
Table of Contents 1. Introduction • Explanation of IBD, its subtypes – Crohn’s disease (CD) and ulcerative colitis (UC) 2. Pediatric Inflammatory Bowel Disease • CD is predominant in the pediatric population 3. Symptoms of IBD: 4. Differences Between Crohn’s...
by MyBiosource Editorial Team | Dec 23, 2018 | News
Table of Contents I. Introduction II. History and Origin III. Diagnosis of Granular Cell Tumor IV. Histological Criteria for Diagnosis of Atypical and Malignant Granular Cell Tumors V. Origin and Occurrence of Granular Cell Tumor VI. Treatment and Prognosis...
by MyBiosource Editorial Team | Dec 23, 2018 | News
Table of Contents 1. Introduction • Immunocompromised patients and their susceptibility to infections and diseases • Causes of immunocompromised states 2. The higher risk of HPV-related cancers among immunocompromised populations 3. The Transplant Cancer Match (TCM)...
by MyBiosource Editorial Team | Dec 2, 2018 | News
Table of Contents I. Introduction II. Influenza Viruses • Types of Influenza Viruses • Genome of Influenza B Virus III. Influenza Virus Proteins • M2 Protein • Matrix Protein (M1) • RNA-dependent RNA Polymerase (RdRp) Subunits (PB1, PB2, and PA) • Neuraminidase (NA) •...
by MyBiosource Editorial Team | Dec 2, 2018 | News
Table of Contents I. Introduction A. Global and US Mortality Rates B. Influenza Virus and Upper Respiratory Tract II. Influenza A Virus Updates A. Family Orthomyxoviridae and Three Genera B. Influenza A and Its Ability to Infect Various Animals C. Structure of...
by MyBiosource Editorial Team | Nov 14, 2018 | News
Table of Contents 1. Introduction 2. Aim of influenza vaccination in Canada and the US 3. Influenza vaccines – Trivalent inactivated vaccines (TIV) and live attenuated influenza vaccines (LAIV) 4. Manufacture of influenza vaccines 5. Recommendations for...
